Related Experiment Video

Updated: Jul 25, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

The preparation and assay of the Rous No. 1 sarcoma agent

J G CARR, R J C HARRIS

    British Journal of Cancer
    |March 1, 1951
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    SARCOMA

    More Related Videos

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
    07:55

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

    Published on: April 11, 2018

    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
    07:18

    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

    Published on: June 13, 2019

    Related Experiment Videos

    Last Updated: Jul 25, 2026

    The In ovo CAM-assay as a Xenograft Model for Sarcoma
    12:44

    The In ovo CAM-assay as a Xenograft Model for Sarcoma

    Published on: July 17, 2013

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
    07:55

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

    Published on: April 11, 2018

    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
    07:18

    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

    Published on: June 13, 2019

    Related Concept Videos

    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

    Articles linked to this work by shared authors, journal, and citation graph.

    Exercises in canine physical rehabilitation: range of motion of the forelimb during stair and ramp ascent.

    The Journal of small animal practice·2013

    Reproducibility and accuracy of gated SPECT for determination of left ventricular volumes and ejection fraction: experimental validation using MRI.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2000

    Hemodynamic evaluation of a chronically implanted, electrically powered left ventricular assist system: responses to acute circulatory stress.

    Journal of the American College of Cardiology·1991

    Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

    The American journal of cardiology·1989

    Temporary left ventricular bypass: factors affecting patient survival.

    Circulation·1979

    A new method for temporary left ventricular bypass. Preclinical appraisal.

    The Journal of thoracic and cardiovascular surgery·1975

    Combining genome-wide polygenic scores with registry data for colorectal cancer risk-based screening.

    British journal of cancer·2026

    Reactivation of DRP1 plays a functional role in resistance to MEK inhibition in pancreatic cancer cells.

    British journal of cancer·2026

    Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis.

    British journal of cancer·2026

    Anthropometric traits, metabolic biomarkers, and pancreatic cancer risk: a causal mediation analysis in UK Biobank.

    British journal of cancer·2026

    TP53 mutation-biased CD8+ T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma.

    British journal of cancer·2026

    Paediatric therapeutic development workshop on medulloblastoma.

    British journal of cancer·2026

    The Therapeutic Potential of Phaseolus vulgaris in Alzheimer's Disease: Insights From Experimental Rodent Model.

    Scientifica·2026

    Diindolylmethane confers nootropic and neuroprotection effects against scopolamine-induced brain injury in Wistar rats.

    3 Biotech·2026

    Differential analysis of ginseng methanol extracts from different origins using FTIR and 2D-COS-IR spectroscopies.

    Analytical methods : advancing methods and applications·2026

    Design Strategies for Developing Chiral Macrocyclic Chelators as a Diagnostic Tool.

    Accounts of chemical research·2026

    ADAPT-M: a workflow for rapid, quantitative in vitro measurements of enriched protein libraries.

    Nature communications·2026

    Integrating Suspect and Nontargeted Screening for Food Safety Testing: A Case Study of Bee Pollen Supplements.

    Analytical chemistry·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us